SavedAdd your journal

Journals / Retina-Vitreus / 2011 / Cilt: 19 - Sayı: 2

Serous macular detachments in inflammatory diseases

İnflamatuvar hastalıklarda görülen seröz maküla dekolmanları

Merih SOYLU
Pages
83–85
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Visual prognosis is usually favorable in serous detachment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Serous macular edema occurs due to leakage of fluid from perifoveal capillaries as a result of disruption of the innerouter blood-retinal barrier.
📊
Key Findings & Data:Serous detachment is usually accompanied cystoid or diffuse macular edema.
💡
Conclusion & Impact:Visual prognosis is usually favorable in serous detachment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Serous macular edema occurs due to leakage of fluid from perifoveal capillaries as a result of disruption of the innerouter blood-retinal barrier. Serous detachment is usually accompanied cystoid or diffuse macular edema. Visual prognosis is usually favorable in serous detachment.

Özet

Seröz maküla dekolmanları, inflamatuvar hastalıklarda içdış kan-retina barieri bozulması sonucu perifoveal kapillerlerden sızan sıvı ile oluşmaktadır. Seröz dekolman (SD), sıklıkla kistoid veya diffüz ödem ile birliktedir. SD’da görsel prognoz iyidir.

🔖

Cite This Article

SOYLU, M. (2011). Serous macular detachments in inflammatory diseases. Retina-Vitreus, Cilt: 19 - Sayı: 2, 83–85. https://ajindex.com/articles/305132

References (10)

  1. Markomichelakis NN, Halkiadakis I, Pantelia E, et al.: Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography. Ophthalmology. 2004;111:946-953
  2. Antcliff RJ, Stanford MR, Chauhan DS, et al.: Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis. Ophthalmology. 2000;107:593-599
  3. Markomichelakis NN, Halkiadakis I, Pantelia E, et al.: Course of macular edema in uveitis under medical treatment. Ocul Immunol Inflamm. 2007;15:71-79
  4. Tran TH, de Smet MD, Bodaghi B, et al.: Uveitic macular oedema: Correlation between optical coherence tomography patterns with visual acuity and fluorescein angiography. Br J Ophthalmol. 2008;92:922-927
  5. Gupta V, Gupta P, Singh R, et al.: Spectral-domain Cirrus high-definition optical coherence tomography is better than time-domain Stratus optical coherence tomography for evaluation of macular pathologic features in uveitis. Am J Ophthalmol. 2008;145:1018-1022
  6. Unoki N, Nishijima K, Kita M, et al.: Structural changes of fovea during remission of Behçet’s disease as imaged by spectral domain optical coherence tomography. Eye. 2010;24:969-975
  7. Lasave AF, Zeballos DG, El-Haig WM, et al.: Short-term results of a single intravitreal bevacizumab (avastin) injection versus a single intravitreal triamcinolone acetonide (kenacort) injection for the management of refractory noninfectious uveitic cystoid macular edema. Ocul Immunol Inflamm. 2009;17:423-430
  8. Androudi S, Tsironi E, Kalogeropoulos C, et al.: Intravitreal adalimumab for refractory uveitis-related macular edema. Ophthalmology. 2010;117:1612-1616
  9. Park HS, Nam KY, Kim JY.: Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt-Koyanagi- Harada disease. Graefes Arch Clin Exp Ophthalmol. 2010;6
  10. Wang J, Ibrahim M, Turkcuoglu P, et al.: Intercellular adhesion molecule inhibitors as potential therapy for refractory uveitic macular edema. Ocul Immunol Inflamm. 2010;18:395-398.